Goldman Sachs Group Inc Bio Rad Laboratories, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 104,874 shares of BIO stock, worth $32.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104,874
Previous 105,006
0.13%
Holding current value
$32.8 Million
Previous $25.6 Million
1.04%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding BIO
# of Institutions
426Shares Held
19.2MCall Options Held
10.7KPut Options Held
35.5K-
First Eagle Investment Management, LLC2.52MShares$786 Million1.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$577 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$484 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1MShares$312 Million0.06% of portfolio
-
Veritas Asset Management LLP863KShares$270 Million2.27% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $7.7B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...